AbCellera Biologics Inc. (ABCL) vs Relay Therapeutics, Inc. (RLAY)
A side-by-side comparison of AbCellera Biologics Inc. and Relay Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABCL
AbCellera Biologics Inc.
$13.16HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
RLAY
Relay Therapeutics, Inc.
$18.23HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — ABCL vs RLAY
growth of $100 · dividends reinvested · last 6yABCL -76.6% (-21.5%/yr)RLAY -61.3% (-14.6%/yr)RLAY compounded faster over this window
ABCL RLAY
ABCL vs RLAY: by the numbers
- •ABCL is the larger company ($4.02B vs $3.99B market cap).
- •Both run net losses; ABCL's is the smaller (-248.83% vs -2763.64% net margin).
- •Both shrank revenue over the past five years; ABCL's decline was smaller (-31.78% vs -34.29% CAGR).
Metrics side by side
Valuation
| Metric | ABCL | RLAY |
|---|---|---|
| P/S ratio | 60.73 | 385.99 |
| P/B ratio | 4.49 | 4.49 |
Profitability
| Metric | ABCL | RLAY |
|---|---|---|
| Gross margin | 61.64% | 76.83% |
| Operating margin | -288.98% | -1971.59% |
| Net margin | -248.83% | -2763.64% |
| ROE | -18.38% | -32.14% |
| ROIC | -17.95% | -33.87% |
Growth (annualized)
| Metric | ABCL | RLAY |
|---|---|---|
| Revenue CAGR (5Y) | -31.78% | -34.29% |
| Total return CAGR (5Y) | -3.57% | -7.92% |
Frequently asked
- Which has grown faster, ABCL or RLAY?
- Neither grew: over the past five years both shrank revenue, with ABCL's decline the smaller — ABCL at a -31.78% CAGR versus RLAY at -34.29%.
- How have ABCL and RLAY total returns compared?
- Over the past 5 years, ABCL delivered -3.57% and RLAY delivered -7.92% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.